These two studies have provided the first genomic landscape of glioblastomas showing some core signaling pathways activated in glioblastomas, which are basically represented by the TP53 pathway, the RB pathway, and the RTK pathway [9,10]. The gene discussed is TP53; the disease is glioblastoma.